Short stature in children: how to assess and when to refer

Dilemmas in paediatrics: GPSI in paediatrics Dr David Capehorn explains how to assess children presenting with short stature and when referral should be considered

Short stature is a well-recognized presentation in primary care, frequently driven by parental anxiety regarding a child’s growth.

Most children referred with short stature will ultimately be diagnosed with a normal growth variant, but growth failure may occasionally be the first sign of significant underlying pathology.

The core challenge for GPs is to identify which children need reassurance and monitoring and which require formal investigation or referral.

Definition and prevalence

Short stature is defined as a height below the second centile, or a height standard deviation score (SDS) below –2, for age and sex.^1,2 Around 2% of the healthy population falls into this category. In England, the most deprived areas have twice the prevalence of short stature compared with the least deprived areas.³

Girls and children from ethnic minority groups are less likely to be referred, assessed and treated for short stature despite having comparable clinical need.⁴This may partly reflect societal and parental perceptions, whereby short stature is often viewed as more concerning in boys than in girls, potentially influencing consultation and referral behaviour.

Pathology and key features

The aetiologies of short stature are broadly categorised into primary growth disorders (intrinsic to the growth plate), secondary growth disorders (extrinsic factors) and idiopathic variants. Most children presenting to a GP have normal variants: either familial short stature or constitutional delay of growth and puberty (CDGP).^5,6

Pathological causes include endocrine disorders (such as growth hormone deficiency or hypothyroidism), coeliac disease, chronic inflammatory conditions (e.g. Crohn’s disease), genetic syndromes (such as Turner syndrome or Noonan syndrome), nutritional problems and psychosocial deprivation.⁷

For GPs evaluating these patients, three questions are clinically paramount:

Has the child been measured accurately?
Are they growing normally over time?
Are they growing within their genetic potential?

Assessment and key diagnostic principles

Accurate measurement

Assessment starts with accurate measurement. Errors in measuring and plotting height – and failure to account for parental height – are common causes of inappropriate referrals.

Children over 2 years should have standing height measured using a calibrated, wall-mounted stadiometer (shoes removed, head in the Frankfort plane – with the external ear canal level with the lower margin of the eye socket). Younger children require length measurement using a horizontal infantometer.

Measurements must be plotted on the appropriate UK-WHO growth charts.⁸ A child dropping through two major centile spaces on the UK-WHO chart over an adequate interval (typically at least 6–12 months in a prepubertal child) – even from a height that appears ‘normal’ – warrants closer attention, as this is recognised as a red flag requiring further assessment.

If serial measurements over an adequate period are available, growth velocity can provide useful supplementary information. In prepubertal children over 3 years of age, the expected growth velocity is approximately 4–8 cm per year.⁹

Box 1. Tips for measuring growth

Measure height accurately using proper equipment (shoes removed, head in the Frankfort plane).
Plot serial measurements over an adequate interval (usually at least 6 months) to assess whether the child continues to track along their expected centile.
Crossing two or more major centile spaces downward on the UK-WHO chart matters more than being short alone.
If measurements available check growth velocity; less than 4 cm/year in a prepubertal child over 3 years of age is an additional red flag.
Compare the child’s height with their genetic potential (midparental height; MPH – see box 2 below).
Measure parental heights in surgery rather than relying on verbal reports.
Refer if the child is significantly below MPH expectations (see next section).
A relatively short, obese child warrants closer endocrine assessment.
Be aware of referral inequity: girls and children from ethnic minority groups are under-referred.

How to use MPH: a key primary care tool

Midparental height is one of the most useful tools when assessing short stature. Establishing that a child is growing within their genetic potential can provide significant reassurance. Parental heights should be measured in surgery rather than relying on verbal reports, which are notoriously inaccurate.⁹

Box 2. How to calculate MPH

Boys: MPH = (Father’s height + Mother’s height + 13) ÷ 2

Girls: MPH = (Father’s height + Mother’s height − 13) ÷ 2

(All heights in centimetres.)

The calculated MPH should be plotted on the adult height scale of the UK-WHO growth chart to determine the child’s expected height centile. The target height range is MPH ± 10 cm (approximately two centile spaces on the UK-WHO chart). Around 90% of children grow within two major centile spaces of their MPH centile. For example, a child whose calculated MPH plots on the 25th centile would generally be expected to grow somewhere between the 9th and 50th centiles.

A child whose height is more than two to three major centile spaces below their expected MPH requires further assessment.

Note that the RCPCH digital growth charts use a statistically more refined method based on parental height z-scores, which is particularly useful when parental heights are discordant; the formula above is a practical clinical approximation.^9,10

Normal variants versus pathological patterns

Familial short stature describes a healthy child who is short but growing at a normal velocity, with a height that is appropriate for parental stature.

Constitutional delay of growth and puberty (CDGP) is also common, especially in boys. These children are short during childhood due to delayed skeletal maturation and puberty, often accompanied by a family history of late development. Their growth velocity may temporarily slow relative to peers entering early puberty, but their final adult height is usually within their normal genetic target range.¹¹

Recognising these patterns in primary care avoids unnecessary investigations and reduces parental anxiety.

History and examination

A focused history should include: birth weight and gestation (to identify being small for gestational age [SGA]); nutrition; gastrointestinal symptoms; chronic illnesses; medication use (especially systemic or high-dose inhaled corticosteroids, including assessing compliance, technique, and spacer use); pubertal development; and a family history of short stature or delayed puberty.

Physical examination should assess absolute height and weight centiles, body proportions (looking for skeletal dysplasia), dysmorphic features, pubertal staging, signs of chronic disease (such as clubbing or thyroid goitre) and psychosocial or safeguarding concerns.

Evaluating weight alongside height is important. Chronic systemic diseases (such as coeliac disease or inflammatory bowel disease) often affect both weight and height, with weight parameters frequently dropping first. Endocrine disorders (such as hypothyroidism or growth hormone deficiency) typically impair linear growth while weight is preserved or increased. Because obese children are generally taller than average due to accelerated bone maturation, a relatively short, obese child warrants a lower threshold for endocrine assessment.

Box 3. Red flags

Height at or below the 0.4th centile.
Height at or below the 2nd centile with additional clinical concerns.
Downward crossing of two or more major centile spaces on the UK-WHO growth chart over an adequate interval (typically at least 6–12 months).
Poor growth velocity (<4 cm/year in a prepubertal child over 3 years of age).
Height significantly below genetic potential (>2–3 centile spaces below MPH centile).
Delayed puberty (no breast development in girls by age 13; no testicular enlargement in boys by age 14).
Dysmorphic features or disproportionate short stature.
Systemic symptoms suggestive of chronic illness (e.g. unexplained fatigue, chronic diarrhoea, weight faltering).
Any girl with unexplained short stature, in the absence of other clinical features (Turner syndrome should be considered).
Born small for gestational age (SGA) without catch-up growth by 2–3 years of age.

These criteria reflect current BSPED referral guidance.^2.7

Initial investigations

If pathology is clinically suspected, or if the child meets referral thresholds, baseline investigations can be initiated in primary care to facilitate secondary care triage:

Full blood count (FBC) and ESR/CRP (to screen for anaemia and occult inflammation).
Coeliac serology (tissue transglutaminase [tTG] IgA and total IgA).
Urea, electrolytes, and liver function tests.
Calcium, phosphate, and alkaline phosphatase.
Thyroid function tests (TSH and free T4).

Some regional paediatric endocrine referral pathways recommend obtaining IGF-1 levels and/or a bone age X-ray as part of the initial assessment of short stature before or alongside specialist referral, although interpretation of bone age is generally most meaningful in conjunction with paediatric endocrine review.¹²

Box 4. Example case studies of short stature in children

Case study 1: Familial short stature

A 6-year-old boy is brought to clinic because his parents are concerned he is ‘the smallest in his class’. Examination reveals no dysmorphic features or signs of systemic illness. His height sits on the 9th centile and his weight on the 25th centile. Review of his personal child health record shows he has grown 5.5 cm over the previous year, tracking along the 9th centile without crossing lines.

His father’s measured height is 178 cm and his mother’s measured height is 160 cm.

MPH (boy) = (178 + 160 + 13) ÷ 2 = 175.5 cm

An adult height of 175.5 cm maps close to the 25th centile. His current height centile is within two centile spaces of his genetic potential, his growth velocity is completely normal for his age, and there are no red flags.

Management: Reassurance is given to the parents. No blood investigations are required. Repeat height measurement in 6–12 months is scheduled in primary care to monitor velocity.

Case study 2: Short stature with underlying pathology

An 8-year-old girl presents with a history of poor growth over several years. Her growth chart demonstrates that her height has fallen from the 25th centile to just below the 2nd centile over a two-year period, crossing two centile spaces. Her weight gain has also plateaued. Upon direct questioning, her mother reports intermittent abdominal bloating and occasional loose stools. On examination, she appears pale but has no dysmorphic features. Baseline blood tests demonstrate iron deficiency anaemia (Hb 98 g/L, low ferritin) and a strongly positive tissue transglutaminase (tTG) IgA antibody.

Management: This case highlights why longitudinal growth trends matter more than a single isolated measurement. Downward centile crossing associated with gastrointestinal symptoms and iron deficiency anaemia points toward a malabsorptive pathology. The patient was referred to paediatric gastroenterology; confirmed coeliac disease was managed with a gluten-free diet, and catch-up growth is anticipated. Linear growth velocity would usually be expected to improve over the subsequent 6–12 months following introduction of a gluten-free diet, although complete centile recovery may take considerably longer depending on duration of disease and pubertal timing. Failure to demonstrate improving growth velocity should prompt reassessment of dietary adherence or consideration of alternative/additional pathology.

Key points

While most children presenting with short stature will ultimately be diagnosed with a normal growth variant, growth failure can be the earliest clinical sign of significant underlying systemic or endocrine pathology.

For the practising GP, the most effective strategy is systematic: measure accurately, calculate midparental height to gauge genetic expectations, look for explicit red flags, investigate selectively and reassure confidently when normal parameters are fulfilled.